Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Hooman Bahrmandy"'
Autor:
Mohammad Ali Zare, Hadi Z Mehrjardi, Mohsen Afarideh, Hooman Bahrmandy, Seyed-Farzad Mohammadi
Publikováno v:
Journal of Ophthalmic & Vision Research, Vol 11, Iss 1, Pp 17-25 (2016)
Purpose: To report visual outcomes and corneal biomechanical changes after femtosecond-assisted Intacs SK implantation in keratoconic eyes. Methods: This prospective interventional case series is comprised of 32 keratoconic eyes of 25 patients with m
Externí odkaz:
https://doaj.org/article/b9ead060cd9a48e48d37d61ed8d71060
Publikováno v:
Journal of Ophthalmic & Vision Research, Vol 11, Iss 1, Pp 17-25 (2016)
Journal of Ophthalmic & Vision Research
Journal of Ophthalmic & Vision Research
Purpose: To report visual outcomes and corneal biomechanical changes after femtosecond-assisted Intacs SK implantation in keratoconic eyes. Methods: This prospective interventional case series is comprised of 32 keratoconic eyes of 25 patients with m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0117c3dacf99e54b6bf5014fe0833199
http://www.jovr.org/article.asp?issn=2008-322X
http://www.jovr.org/article.asp?issn=2008-322X
Autor:
Hooman Bahrmandy, Hassan Hashemi, Shahab Heidarian, Hamidreza Nikbin, Akbar Fotouhi, Kazem Amanzadeh, Soheila Asgari, Mohammad Miraftab, Mohammad Amin Seyedian
Publikováno v:
Journal of Cataract and Refractive Surgery. 41:533-540
Purpose To compare the 6-month results of accelerated and standard collagen crosslinking (CXL) treatment of progressive keratoconus. Setting Noor Eye Hospital, Tehran, Iran. Design Prospective randomized clinical trial. Methods Two groups of eyes (in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce268129b760915777f2148f632cfe67
https://doi.org/10.1016/j.jcrs.2014.07.030
https://doi.org/10.1016/j.jcrs.2014.07.030
Autor:
Shahab Heidarian, Hooman Bahrmandy, Kazem Amanzadeh, Hassan Hashemi, Mohammad Amin Seyedian, Hamidreza Nikbin, Soheila Asgari, Akbar Fotouhi, Mohammad Miraftab, Farhad Hafezi
Publikováno v:
American journal of ophthalmology. 160(6)
To compare the long-term outcomes of accelerated and standard corneal cross-linking protocols in the treatment of progressive keratoconus.Prospective randomized clinical trial.Thirty-one eyes with keratoconus were treated with an accelerated protocol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88051264f54c52731debf712dcf55547
https://pubmed.ncbi.nlm.nih.gov/26314662
https://pubmed.ncbi.nlm.nih.gov/26314662
Autor:
Hooman Bahrmandy, Araz Sabzevari, Hassan Hashemi, Soheila Asgari, Mohammad Amin Seyedian, Mohammad Miraftab
Publikováno v:
DARU Journal of Pharmaceutical Sciences
Background To compare the 6-month results of two formulations of Riboflavin provided by Sina Darou, Iran, and Uznach, Switzerland, in corneal collagen cross-linking (CXL) for keratoconus patients. Findings Considering the results of the previous stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d42217f8efdcdb4ac471d27245f48df6
https://doi.org/10.1186/2008-2231-22-37
https://doi.org/10.1186/2008-2231-22-37
Autor:
Hooman Bahrmandy, Mohammad Miraftab, Hassan Hashemi, Soheila Asgari, Mohammad Amin Seyedian, Araz Sabzevari
Publikováno v:
DARU Journal of Pharmaceutical Sciences
Background Comparison of long-term clinical results of two different pharmaceutical formulations used in corneal cross-linking (CXL) in keratoconus patients. Methods Sixty eyes of 60 keratoconus patients underwent CXL in two groups. We used riboflavi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cef942dee03b3a4e11af7adb829d063